Behavioral Health Care Of Cape

Details Contact
Medical Suppliers In North Carolina

Name :

Behavioral Health Care Of Cape

Address  :

3425 Melrose Road

Town  :

Fayetteville

State  :

North Carolina

Country  :

USA

Post Code:

28304 1695

Phone  :

910 609 3000

Fax  :

910 609 3091

Web URL  :

Available

Email  :

dbyers@capefearvalley.com
Specialization
  • Anaesthesiology
  • Cardiology
  • Daibetes, Endocrinology
  • Dentistry
  • Dermatology
  • Gastro-enterology
  • General Surgeon
  • Internal Medicine
  • Neuro Surgeon
  • Neurologist
  • Obestetrician/Gynecologist
  • Oncologist
  • Ophthalmology
  • Orthopedics
  • Otolaryngologist
  • Paediatrics
  • Pain Management
  • Plastic Surgery
  • Podiatry
  • Psychiatrist
  • Pulmonology
  • Urology
Facilities

Total Number Of Beds : 426

Description
Behavioral Health Care
Cape Fear Valley Behavioral Health Care offers inpatient mental health services for adults and outpatient services for children ages four and older adolescents and adults It is located at 3425 Melrose Road in Fayetteville

Behavioral Health Care offers psychiatric treatment including evaluations medical management and group family and individual therapy Substance abuse treatment is also available

Behavioral Health Care is accredited by The Joint Commission and licensed by the state of North Carolina Staffed by psychiatrists psychologists clinical social workers psychiatric nurses licensed professional counselors and other mental health professionals Cape Fear Valley Behavioral Health Care provides a team approach to mental wellness
NEWS
Hospitals Are Allowed to Not Hire Fat People

Smokers must step outside to puff Mandatory drug screening eliminates users from employment whether theyre high on the job or not Now the Texas Tribune reports that Citizens Medical Center in Victoria Texas is adding another health issue to the list of workplace nonos obesity If your body mass index BMI is over 35 you cant get a job at Citizens... Read More

ARTICLES
Group B Neisseria meningitidis Vaccine Shows Promise

An investigational vaccine may represent a strong lead in the fight against group B Neisseria meningitidis according to results of a phase 2 study published online in the Lancet Administered in 3 doses over the course of 6 months a new bivalent vaccine was well tolerated and induced a strong immune response against multiple strains of the poten... Read More